PASADENA, Calif., April 25, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2022.

Alexandria Real Estate Equities, Inc. All Rights Reserved ©2022 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All Rights Reserved ©2022 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All Rights Reserved ©2022 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All Rights Reserved ©2022 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

 

Key highlights





Operating results

1Q22


1Q21


Total revenues:





     In millions

$

615.1


$

479.8


     Growth


28.2%



Net (loss) income attributable to Alexandria's common stockholders – diluted

     In millions 

$

(151.7)


$

6.1


     Per share

$

(0.96)


$

0.04


Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted

     In millions

$

324.6


$

263.0


     Per share

$

2.05


$

1.91


Continued strong leasing volume in 1Q22, after a historic year of leasing in 2021

  • Strong leasing activity continued in 1Q22 with the second-highest leasing volume in Company history for both total space and development and redevelopment space:


1Q22


Total leasing activity – RSF


2,463,438


Leasing of development and redevelopment space – RSF


1,439,696


Lease renewals and re-leasing of space:




     RSF (included in total leasing activity above)


864,077


     Rental rate increases


32.2%


     Rental rate increases (cash basis)


16.5%


Excluding short-term renewals executed to allow Bristol-Myers Squibb Company ("BMS") to expand
and consolidate into our Alexandria Point development project, described further below:


     Rental rate increases


39.8%


     Rental rate increases (cash basis)


23.2%


  • During 1Q22, we executed the following long-term leases:
    • 426,927 RSF with BMS, our largest tenant, for the development of BMS's newest innovative cutting-edge research hub focused on cancer as well as immune-mediated and neurodegenerative diseases at the Alexandria Point mega campus in San Diego.
    • 333,929 RSF with Eli Lilly and Company ("Lilly"), our third largest tenant, for the development of Lilly's new state-of-the-art Institute for Genetic Medicine at 15 Necco Street in our Seaport Innovation District submarket of Greater Boston.

Continued strong net operating income and internal growth

  • Net operating income (cash basis) of $1.5 billion for 1Q22 annualized, up $301.3 million, or 24.9%, compared to 1Q21 annualized.
  • 97% of our leases contain contractual annual rent escalations approximating 3%.
  • 7.6% and 7.3% (cash basis) same property net operating income increase for 1Q22 over 1Q21.

A REIT industry-leading high-quality tenant roster with high-quality revenues and cash flows, strong margins, and operational excellence

Percentage of total annual rental revenue in effect from investment-grade or
     publicly traded large cap tenants


50%








Occupancy of operating properties in North America


94.7%



Occupancy of operating properties in North America (excluding vacancy at
     recently acquired properties)


98.6%

(1)


Operating margin


71%



Adjusted EBITDA margin


71%








Weighted-average remaining lease term:





     All tenants


7.3

years

     Top 20 tenants


10.5

years



(1)

Excludes 1.6 million RSF, or 3.9%, of vacancy at recently acquired properties representing lease-up opportunities that are expected to provide incremental annual rental revenue. Refer to "Occupancy" in our Supplemental Information.

100 Binney Street achieves $1 billion valuation milestone in recapitalization

During 1Q22, we completed the sale of a 70% interest in 100 Binney Street in our Cambridge/Inner Suburbs submarket of Greater Boston for a sales price of $713.2 million, or $2,353 per RSF, at capitalization rates of 3.6% and 3.5% (cash basis), representing an excess of $413.6 million above our book value of the 70% interest sold. The sales price at 100% represents a property valuation of $1.02 billion. Proceeds from this sale will be reinvested into our highly leased value-creation pipeline and acquisitions with development and redevelopment opportunities.

Continued high demand drives visibility for future growth aggregating $665 million of incremental annual rental revenue

Our highly leased value-creation pipeline of current and key near-term projects that are under construction or that will commence construction in the next six quarters is expected to generate greater than $665 million of incremental annual rental revenue, primarily commencing from 2Q22 through 1Q25.

  • 8.0 million RSF of our value-creation projects are either under construction or expected to commence construction in the next six quarters.
  • 77% leased/negotiating.

Strong and flexible balance sheet with significant liquidity

  • Investment-grade credit ratings ranked in the top 10% among all publicly traded U.S. REITs as of March 31, 2022.
  • Net debt and preferred stock to Adjusted EBITDA of 5.5x and fixed-charge coverage ratio of 5.1x for 1Q22 annualized.
  • Total debt and preferred stock to gross assets of 28% as of March 31, 2022.
  • $5.7 billion liquidity as of March 31, 2022.

Continued dividend strategy to share growth in cash flows with stockholders

Common stock dividend declared for 1Q22 of $1.15 per common share, aggregating $4.54 per common share for the twelve months ended March 31, 2022, up 24 cents, or 6%, over the twelve months ended March 31, 2021. Our FFO payout ratio of 57% for the three months ended March 31, 2022 allows us to continue to share growth in cash flows from operating activities with our stockholders while also retaining a significant portion for reinvestment.

Key items included in operating results

Key items included in net (loss) income attributable to Alexandria's common stockholders:










(In millions, except per share amounts)

Amount


Per Share – Diluted



1Q22


1Q21


1Q22


1Q21


Unrealized losses on non-real estate investments

$   (263.4)


$      (46.3)


$     (1.67)


$     (0.34)


Significant realized gains on non-real estate investments


22.9



0.17


Gain on sales of real estate


2.8



0.02


Impairment of real estate


(5.1)



(0.04)


Loss on early extinguishment of debt


(67.3)



(0.49)


   Total

$   (263.4)


$      (93.0)


$     (1.67)


$     (0.68)


External growth and investment in real estate

Alexandria at the vanguard of innovation with a focus on accommodating our tenants' current needs and providing a path for their future growth; high-quality roster of over 1,000 tenants

  • During 1Q22, we completed acquisitions in our key life science cluster submarkets aggregating 7.3 million SF and comprising 6.9 million RSF of future development and redevelopment opportunities and 451,760 RSF of operating space for an aggregate purchase price of $1.8 billion. These acquisitions continue to be primarily focused on future development or redevelopment opportunities to expand our mega campuses and accommodate the future growth of our tenants.

Delivery and commencement of value-creation projects

  • During 1Q22, we placed into service development and redevelopment projects aggregating 566,665 RSF across multiple submarkets.
  • 82% of construction costs related to active development and redevelopment projects aggregating 5.4 million RSF are under a guaranteed maximum price contract or other contracts. Our budgets also include a landlord contingency that generally ranges between 3% and 5%. Refer to "Definitions and reconciliations" in our Supplemental Information for additional details.
  • Annual net operating income (cash basis) is expected to increase by $48 million upon the burn-off of initial free rent from recently delivered projects.
  • During 1Q22, we commenced construction on five value-creation projects aggregating 1.1 million RSF, including:
    • 345,995 RSF development project that is 97% leased at 15 Necco Street in our Seaport Innovation District submarket.
    • 300,010 RSF project at 651 Gateway Boulevard in our South San Francisco submarket, which will be redeveloped into office/laboratory space; and
    • 192,000 RSF development project that is 100% leased at 9810 Darnestown Road in our Rockville submarket.

Delivery and commencement of value-creation projects (continued)

Value-creation pipeline of new Class A development and redevelopment projects as
a percentage of gross assets


1Q22

Under construction projects 76% leased/negotiating


9%

Pre-leased/negotiating near-term projects expected to commence construction in
     the next six quarters 82% leased/negotiating


2%

Income-producing/potential cash flows/covered land play(1)


7%

Land


2%




(1)

Includes projects that have existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating campuses.

Balance sheet management

Key metrics as of March 31, 2022

  • $42.8 billion in total market capitalization.
  • $32.5 billion in total equity capitalization, which ranks in the top 10% among all publicly traded U.S. REITs as of March 31, 2022.
  • No debt maturities prior to 2025 as of April 25, 2022.
  • 13.8 years weighted-average remaining term of debt as of March 31, 2022.


1Q22


Goal



Quarter


Trailing


4Q22



Annualized


12 Months


Annualized

Net debt and preferred stock to
     Adjusted EBITDA


5.5x



5.9x


Less than or equal to 5.1x

Fixed-charge coverage ratio


5.1x



5.1x


Greater than or equal to 5.1x


Key capital events

  • During 1Q22, our common equity transactions included the following:
    • In January 2022, we entered into new forward equity sales agreements aggregating $1.7 billion to sell 8.1 million shares of our common stock (including the exercise of an underwriters' option) at a public offering price of $210.00 per share, before underwriting discounts and commissions.
      • In March 2022, we settled a portion of these forward equity sales agreements by issuing 3.2 million shares and received net proceeds of $648.2 million.
      • We expect to issue 4.8 million shares to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $1.0 billion in 2022.
    • In March 2022, we entered into new forward equity sales agreements aggregating $350.0 million to sell 1.8 million shares under our ATM program at an average price of $192.42 per share (before underwriting discounts). We expect to settle these forward equity sales agreements in 2022.
    • As of March 31, 2022, the remaining aggregate amount available under our ATM program for future sales of common stock is $650.0 million.
  • In February 2022, we opportunistically issued $1.8 billion of unsecured senior notes payable with a weighted-average interest rate of 3.28% and a weighted-average maturity of 22.0 years. The unsecured senior notes include:
    • $800.0 million of 2.95% green unsecured senior notes due 2034; and
    • $1.0 billion of 3.55% unsecured senior notes due 2052.

Investments

  • As of March 31, 2022, our investments aggregated $1.7 billion, including unrealized gains of $532.6 million.
  • Investment loss of $240.3 million for the three months ended March 31, 2022 included $23.1 million in realized gains and $263.4 million in unrealized losses (due to changes in fair value).

Subsequent event

  • In April 2022, we repaid two secured notes payable aggregating $195.0 million due in 2024 with an effective interest rate of 3.40% and recognized a loss on early extinguishment of debt of $3.3 million, including a prepayment penalty and the write-off of unamortized loan fees.

Industry and ESG leadership: catalyzing and leading the way for positive change to benefit human health and society

  • In April 2022, 9880 Campus Point Drive, a 98,000 RSF development on the Alexandria Point mega campus in our University Town Center submarket, earned LEED Platinum certification, the highest level of certification under the U.S. Green Building Council's Core & Shell rating system. Home to Alexandria GradLabs®, a dynamic proprietary platform purpose-built to accelerate the growth of promising post-seed-stage life science companies, the cutting-edge facility demonstrates high levels of sustainability, including decreased water consumption, significantly reduced energy use, and increased use of recycled resources and materials.
  • In March 2022, Alexandria's executive chairman and founder, Joel S. Marcus, was honored by the National Medal of Honor Museum Foundation in Arlington, Texas during a groundbreaking ceremony in celebration of the historic mission-critical milestone in the development of the national museum. Mr. Marcus, who serves on the foundation's board of directors, attended alongside fellow foundation board members, major museum donors, government officials, and 15 Medal of Honor recipients to commemorate the foundation's remarkable progress toward its goal to build a permanent home where the inspiring stories of our country's Medal of Honor recipients will be brought to life.
  • In February 2022, Alexandria was ranked the #5 most sustainable REIT, as featured in the Barron's article, "10 Real Estate Companies That Are Both Greener and More Profitable."
  • In February 2022, Alexandria earned the first-ever Fitwel Life Science certification for 300 Technology Square, located on the Alexandria Technology Square® mega campus in our Cambridge/Inner Suburbs submarket. The new rigorous, evidence-based Fitwel Life Science Scorecard — developed in partnership with the Center for Active Design exclusively for Alexandria — is the first healthy building framework dedicated to laboratory facilities, marking another pioneering effort by the company to prioritize tenant health and wellness and further differentiate our world-class laboratory buildings.
  • In January 2022, Alexandria Venture Investments, our strategic venture capital platform, was recognized by Silicon Valley Bank in its "Healthcare Investments and Exits: 2022 Annual Report" as the #1 most active corporate investor in biopharma by new deal volume (2020-2021) for the fifth consecutive year. In March 2022, Alexandria Venture Investments was also recognized by AgFunder in its "2022 AgriFoodTech Investment Report" as one of the five most active U.S. Investors in agrifoodtech by number of companies in which it invested (2021) for the second consecutive year.
  • Several of Alexandria's facilities and campuses across our regions received awards in honor of excellence in operations, development, and design:
    • 200 Technology Square on the Alexandria Technology Square® mega campus in our Cambridge/Inner Suburbs submarket earned a 2022 BOMA Mid-Atlantic TOBY (The Outstanding Building of the Year) award in the Corporate Category. The TOBY Awards honor and recognize quality in building operations and award excellence in building management.
    • The Alexandria Center® for AgTech in our Research Triangle submarket was named Top Flex/Warehouse Development in the Triangle Business Journal's 2022 SPACE Awards. The annual SPACE Awards recognize the Research Triangle's top real estate developments and transactions.
    • 685 Gateway Boulevard, an amenities building on our Alexandria Technology Center® – Gateway mega campus in our South San Francisco submarket, which is on track to achieve Zero Energy Certification, was awarded one of 10 national awards issued by WoodWorks – Wood Products Council in the 2022 Wood Design Awards, an annual awards program that celebrates excellence in wood building design.

 

Acquisitions
March 31, 2022
(Dollars in thousands)











Square Footage













Acquisitions With Development/Redevelopment Opportunities(1)







Property


Submarket/Market


Date of

Purchase


Number of
Properties


Operating

Occupancy


Future
Development


Active
Development/
Redevelopment


Operating With
Future
Development/
Redevelopment


Operating(2)


Operating


Total(3)


Purchase Price

Completed in 1Q22:


























  421 Park Drive(4)


Fenway/Greater Boston


1/13/22



N/A  



202,997

(4)





202,997


$

81,119

(4)

  225 and 235 Presidential Way


Route 128/Greater Boston


1/28/22


2


100%





440,130




440,130



124,673


  1150 El Camino Real


South San Francisco/San
     Francisco Bay Area


2/8/22


1


99



610,000



431,940


70,000



680,000



118,000


  3301, 3303, 3305, and 3307
     Hillview Avenue


Greater Stanford/

     San Francisco Bay Area


1/6/22


4


100





292,013




292,013



446,000


  Costa Verde by Alexandria


University Town Center/

   San Diego


1/11/22


2


100



537,000



8,730




545,730



125,000


  800 Mercer Street (60%
     interest in consolidated JV)


Lake Union/Seattle


3/18/22



N/A  



869,000






869,000



87,608


  Alexandria Center® for Life
     Science – Durham


Research Triangle/
     Research Triangle


1/11/22



N/A  



1,175,000






1,175,000



99,428


  104 and 108/110/112/114 TW
     Alexander Drive, 2752 East
     NC Highway 54, and 10
     South Triangle Drive(5)


Research Triangle/
     Research Triangle


1/6/22


4


89



750,000



69,485




819,485



80,000


  Intersection Campus


Texas/Other


2/18/22


9


81





998,099




998,099



400,400


  Other


Various


Various


7


92



473,994



428,097


381,760



1,283,851



278,489








29


91%



4,617,991



2,668,494

(6)

451,760

(6)

(6)

7,306,305



1,840,717


Other targeted acquisitions
























1,159,283


2022 acquisitions (midpoint)























$

3,000,000




























2022 guidance range





















$2,500,000 – $3,500,000



(1)

We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction.

(2)

Represents the operating component of our value-creation acquisitions that is not expected to undergo future development or redevelopment.

(3)

Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation with future development or redevelopment opportunities. We intend to demolish and develop or to redevelop the existing properties upon expiration of the existing in-place leases. Refer to "Definitions and reconciliations" in our Supplemental Information for additional details on value-creation square feet currently included in rental properties.

(4)

Represents the incremental purchase price related to the achievement of additional entitlement rights aggregating 202,997 SF at our Alexandria Center® for Life Science – Fenway mega campus.

(5)

Includes the acquisition of fee simple interests in the land underlying our recently acquired 108/110/112/114 TW Alexander Drive buildings, which were previously subject to ground leases.

(6)

We expect the acquisitions completed during the three months ended March 31, 2022 to generate initial annual net operating income of approximately $75 million for the twelve months following acquisition. These acquisitions included 29 operating properties with a weighted-average acquisition date of January 23, 2022 (weighted by initial annual net operating income).

 

 

Dispositions and Sales of Partial Interest
March 31, 2022
(Dollars in thousands)

Property


Submarket/Market


Date of
Sale


Interest
Sold


RSF


Capitalization
Rate


Capitalization
Rate
(Cash Basis)


Sales Price


Sales Price
per RSF


Consideration
in Excess of
Book Value




























100 Binney Street


Cambridge/Greater Boston


3/30/22


70%



432,931


3.6%



3.5%



$                               713,228

(1)

$         2,353


$     413,615

(2)




























Other


Greater Boston


2Q22


100%



TBD








300,000

400,000




TBD



Other




TBD


TBD



TBD








286,772

1,486,772




TBD



2022 guidance range

















$  1,300,000

$  2,600,000



































(1)

Represents the contractual sales price for the percentage interest of the property sold by us.

(2)

We retained control over the newly formed real estate joint venture and therefore continued to consolidate this property. We accounted for the difference between the consideration received and the book value of the interest sold as an equity transaction, with no gain or loss recognized in earnings.

 

Guidance
March 31, 2022
(Dollars in millions, except per share amounts)


The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2022. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. Also, refer to our discussion of "forward-looking statements" on page 7 of this Earnings Press Release for additional details.




2022 Guidance




2022 Guidance Midpoint

Summary of Key Changes in Guidance


As of 4/25/22


As of 1/31/22


Summary of Key Changes in Sources and Uses of

     Capital Guidance


As of 4/25/22


As of 1/31/22

EPS, FFO per share, and FFO per share, as adjusted


See updates below


Dispositions and sales of partial interest


$1,950


$1,700

Same property net operating income increases


5.9% to 7.9%


5.5% to 7.5%


Issuance of unsecured senior notes payable


$1,800


$1,450

Straight-line rent revenue


$154 to $164


$150 to $160


Repayments of secured notes payable


$(195)


$—























Projected 2022 Earnings per Share and Funds From Operations per Share Attributable to
     Alexandria's Common Stockholders – Diluted




As of 4/25/22


As of 1/31/22


Earnings per share(1)


$1.08 to $1.18


$2.65 to $2.85


     Depreciation and amortization of real estate assets



5.65




5.65



     Allocation to unvested restricted stock awards



(0.02)




(0.04)



Funds from operations per share(2)


$6.71 to $6.81


$8.26 to $8.46


     Unrealized losses on non-real estate investments



1.67






     Loss on early extinguishment of debt(3)



0.02






     Allocation to unvested restricted stock awards



(0.02)






     Other



(0.05)






Funds from operations per share, as adjusted(2)


$8.33 to $8.43


$8.26 to $8.46


Midpoint


$8.38


$8.36








Key Assumptions


Low


High


Occupancy percentage in North America as of December 31, 2022


95.2%


95.8%


Lease renewals and re-leasing of space:






     Rental rate increases


30.0%


35.0%


     Rental rate increases (cash basis)


18.0%


23.0%


Same property performance:






     Net operating income increase


5.9%


7.9%


     Net operating income increase (cash basis)


6.5%


8.5%


Straight-line rent revenue


$            154


$            164


General and administrative expenses


$            168


$            176


Capitalization of interest


$            269


$            279


Interest expense


$              90


$            100














Key Credit Metrics


2022 Guidance

Net debt and preferred stock to Adjusted EBITDA – 4Q22 annualized


Less than or equal to 5.1x

Fixed-charge coverage ratio – 4Q22 annualized


Greater than or equal to 5.1x




Key Sources and Uses of Capital


Range


Midpoint


Certain
Completed
Items as of
3/31/22

Sources of capital:











     Net cash provided by operating activities after
          dividends


$    275


$    325


$

300




     Incremental debt


1,375


525



950


See below

     Dispositions and sales of partial interest (refer to
          page 5
)


1,300


2,600



1,950


$     713


     Common equity


2,250


3,250



2,750


$  2,040

(4)

Total sources of capital


$ 5,200


$ 6,700


$

5,950




Uses of capital:











     Construction (refer to page 46)


$ 2,700


$ 3,200


$

2,950




     Acquisitions (refer to page 4)


2,500


3,500



3,000


$  1,841


Total uses of capital


$ 5,200


$ 6,700


$

5,950




Incremental debt (included above):











     Issuance of unsecured senior notes payable


$ 1,800


$ 1,800


$

1,800


$  1,800


     Repayments of secured notes payable


(195)


(195)



(195)


$    (195)

(3)

     Unsecured senior line of credit, commercial paper,
          and other


(230)


(1,080)



(655)




Incremental debt


$ 1,375


$    525


$

950

















(1)

Excludes unrealized gains or losses after March 31, 2022 that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.

(2)

Refer to "Funds from operations and funds from operations, as adjusted, attributable to Alexandria's common stockholders" in the "Definitions and reconciliations" of our Supplemental Information for additional details.

(3)

Refer to "Subsequent event" on page 3 of this Earnings Press Release for additional details.

(4)

Refer to "Key capital events" on page 2 of this Earnings Press Release for additional details. During the three months ended March 31, 2022, we entered into new forward equity sales agreements aggregating $2.0 billion to sell 9.9 million shares of our common stock. As of March 31, 2022, we settled a portion of these forward equity sales agreements by issuing 3.2 million shares and received net proceeds of $648.2 million. We expect to issue 6.6 million shares to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $1.3 billion in 2022.

 

Earnings Call Information and About the Company
March 31, 2022

We will host a conference call on Tuesday, April 26, 2022, at 3:00 p.m. Eastern Time ("ET")/noon Pacific Time ("PT"), which is open to the general public, to discuss our financial and operating results for the first quarter ended March 31, 2022. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 3:00 p.m. ET/noon PT and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the "For Investors" section. A replay of the call will be available for a limited time from 5:00 p.m. ET/2:00 p.m. PT on Tuesday, April 26, 2022. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 3372112.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the first quarter ended March 31, 2022 is available in the "For Investors" section of our website at www.are.com or by following this link: http://www.are.com/fs/2022q1.pdf.

For any questions, please contact Joel S. Marcus, executive chairman and founder; Peter M. Moglia, co-chief executive officer and co-chief investment officer; Stephen A. Richardson, co-chief executive officer; Dean A. Shigenaga, president and chief financial officer; Paula Schwartz, managing director of Rx Communications Group, at (917) 322-2216; or Sara M. Kabakoff, vice president – communications, at (626) 578-0777.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, with a total market capitalization of $42.8 billion and an asset base in North America of 74.2 million square feet ("SF") as of March 31, 2022. The asset base in North America includes 41.9 million RSF of operating properties and 5.4 million RSF of Class A properties undergoing construction, 10.4 million RSF of near-term and intermediate-term development and redevelopment projects, and 16.5 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

***********

This document includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2022 earnings per share attributable to Alexandria's common stockholders – diluted, 2022 funds from operations per share attributable to Alexandria's common stockholders – diluted, net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as "forecast," "guidance," "goals," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," "targets," or "will," or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties, assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, lower than expected yields, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, failure to obtain LEED and other healthy building certifications and efficiencies, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission ("SEC"). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated, we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

Alexandria®, Lighthouse Design® logo, Building the Future of Life-Changing Innovation®, That's What's in Our DNA®, GradLabs®, Alexandria Center®, Alexandria Technology Square®, Alexandria Technology Center®, and Alexandria Innovation Center® are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names, trademarks, and logos referenced herein are the property of their respective owners.

 

Consolidated Statements of Operations
March 31, 2022
(Dollars in thousands, except per share amounts)




Three Months Ended



3/31/22


12/31/21


9/30/21


6/30/21


3/31/21

Revenues:











    Income from rentals


$       612,554


$       574,656


$       546,527


$       508,371


$       478,695

    Other income


2,511


2,267


1,232


1,248


1,154

Total revenues


615,065


576,923


547,759


509,619


479,849












Expenses:











    Rental operations


181,328


175,717


165,995


143,955


137,888

    General and administrative


40,931


41,654


37,931


37,880


33,996

    Interest


29,440


34,862


35,678


35,158


36,467

    Depreciation and amortization


240,659


239,254


210,842


190,052


180,913

    Impairment of real estate




42,620


4,926


5,129

    Loss on early extinguishment of debt






67,253

Total expenses


492,358


491,487


493,066


411,971


461,646












Equity in earnings of unconsolidated real estate joint ventures


220


3,018


3,091


2,609


3,537

Investment (loss) income


(240,319)


(112,884)


67,084


304,263


1,014

Gain (loss) on sales of real estate



124,226


(435)



2,779

Net (loss) income


(117,392)


99,796


124,433


404,520


25,533

Net income attributable to noncontrolling interests


(32,177)


(24,901)


(21,286)


(19,436)


(17,412)

Net (loss) income attributable to Alexandria Real Estate Equities, Inc.'s stockholders


(149,569)


74,895


103,147


385,084


8,121

Net income attributable to unvested restricted stock awards


(2,081)


(2,098)


(1,883)


(4,521)


(2,014)

Net (loss) income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders


$      (151,650)


$         72,797


$       101,264


$       380,563


$           6,107












Net (loss) income per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders:











    Basic


$            (0.96)


$             0.47


$             0.67


$             2.61


$             0.04

    Diluted


$            (0.96)


$             0.47


$             0.67


$             2.61


$             0.04












Weighted-average shares of common stock outstanding:











    Basic


158,198


153,464


150,854


145,825


137,319

    Diluted


158,198


154,307


151,561


146,058


137,688












Dividends declared per share of common stock


$             1.15


$             1.15


$             1.12


$             1.12


$             1.09

 

Consolidated Balance Sheets
March 31, 2022
(In thousands)




3/31/22


12/31/21


9/30/21


6/30/21


3/31/21

Assets











Investments in real estate


$  27,100,009


$  24,980,669


$  23,071,514


$  21,692,385


$  20,253,418

Investments in unconsolidated real estate joint ventures


38,456


38,483


321,737


323,622


325,928

Cash and cash equivalents


775,060


361,348


325,872


323,876


492,184

Restricted cash


95,106


53,879


42,182


33,697


42,219

Tenant receivables


7,570


7,379


7,749


6,710


7,556

Deferred rent


881,743


839,335


816,219


781,600


751,967

Deferred leasing costs


484,184


402,898


329,952


321,005


294,328

Investments


1,661,101


1,876,564


2,046,878


1,999,283


1,641,811

Other assets


1,801,027


1,658,818


1,596,615


1,536,672


1,424,935

Total assets


$  32,844,256


$  30,219,373


$  28,558,718


$  27,018,850


$  25,234,346












Liabilities, Noncontrolling Interests, and Equity











Secured notes payable


$       208,910


$       205,198


$       198,758


$       227,984


$       229,406

Unsecured senior notes payable


10,094,337


8,316,678


8,314,851


8,313,025


8,311,512

Unsecured senior line of credit and commercial paper



269,990


749,978


299,990


Accounts payable, accrued expenses, and other liabilities


2,172,692


2,210,410


2,149,450


1,825,387


1,750,687

Dividends payable


187,701


183,847


173,560


170,647


160,779

Total liabilities


12,663,640


11,186,123


11,586,597


10,837,033


10,452,384












Commitments and contingencies






















Redeemable noncontrolling interests


9,612


9,612


11,681


11,567


11,454












Alexandria Real Estate Equities, Inc.'s stockholders' equity:











    Common stock


1,614


1,580


1,532


1,507


1,457

    Additional paid-in capital


16,934,094


16,195,256


14,727,735


14,194,023


12,994,748

    Accumulated other comprehensive loss


(5,727)


(7,294)


(6,029)


(4,508)


(5,799)

Alexandria Real Estate Equities, Inc.'s stockholders' equity


16,929,981


16,189,542


14,723,238


14,191,022


12,990,406

Noncontrolling interests


3,241,023


2,834,096


2,237,202


1,979,228


1,780,102

Total equity


20,171,004


19,023,638


16,960,440


16,170,250


14,770,508

Total liabilities, noncontrolling interests, and equity


$  32,844,256


$  30,219,373


$  28,558,718


$  27,018,850


$  25,234,346

 

Funds From Operations and Funds From Operations per Share
March 31, 2022
(In thousands)


The following table presents a reconciliation of net income (loss) attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles ("GAAP"), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria's common stockholders – diluted, and funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below:




Three Months Ended



3/31/22


12/31/21


9/30/21


6/30/21


3/31/21

Net (loss) income attributable to Alexandria's common stockholders


$  (151,650)


$     72,797


$   101,264


$   380,563


$       6,107

    Depreciation and amortization of real estate assets


237,160


234,979


205,436


186,498


177,720

    Noncontrolling share of depreciation and amortization from consolidated real estate JVs


(23,681)


(21,265)


(17,871)


(16,301)


(15,443)

    Our share of depreciation and amortization from unconsolidated real estate JVs


955


3,058


3,465


4,135


3,076

     (Gain) loss on sales of real estate



(124,226)


435



(2,779)

    Impairment of real estate – rental properties




18,602


1,754


5,129

    Allocation to unvested restricted stock awards




(1,472)


(2,191)


(201)

Funds from operations attributable to Alexandria's common stockholders – diluted(1)


62,784


165,343


309,859


554,458


173,609

    Unrealized losses (gains) on non-real estate investments


263,433


139,716


14,432


(244,031)


46,251

    Significant realized gains on non-real estate investments




(52,427)


(34,773)


(22,919)

    Impairment of real estate




24,018


3,172


    Loss on early extinguishment of debt






67,253

    Allocation to unvested restricted stock awards


(1,604)


(1,432)


149


3,428


(1,208)

Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted


$   324,613


$   303,627


$   296,031


$   282,254


$   262,986



(1)

Calculated in accordance with standards established by the Nareit Board of Governors. 

 

Funds From Operations and Funds From Operations per Share (continued)
March 31, 2022
(In thousands, except per share amounts)


The following table presents a reconciliation of net income (loss) per share attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria's common stockholders – diluted, and funds from operations per share attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to rounding.




Three Months Ended



3/31/22


12/31/21


9/30/21


6/30/21


3/31/21

Net (loss) income per share attributable to Alexandria's common stockholders – diluted


$        (0.96)


$         0.47


$         0.67


$         2.61


$         0.04

    Depreciation and amortization of real estate assets


1.36


1.40


1.26


1.19


1.20

     (Gain) loss on sales of real estate



(0.80)




(0.02)

    Impairment of real estate – rental properties




0.12


0.01


0.04

    Allocation to unvested restricted stock awards




(0.01)


(0.01)


Funds from operations per share attributable to Alexandria's common stockholders – diluted


0.40


1.07


2.04


3.80


1.26

    Unrealized losses (gains) on non-real estate investments


1.67


0.91


0.10


(1.67)


0.34

    Significant realized gains on non-real estate investments




(0.35)


(0.24)


(0.17)

    Impairment of real estate




0.16


0.02


    Loss on early extinguishment of debt






0.49

    Allocation to unvested restricted stock awards


(0.02)


(0.01)



0.02


(0.01)

Funds from operations per share attributable to Alexandria's common stockholders – diluted, as adjusted


$         2.05


$         1.97


$         1.95


$         1.93


$         1.91












Weighted-average shares of common stock outstanding for calculation of:











    Earnings per share – diluted


158,198


154,307


151,561


146,058


137,688

    Funds from operations, diluted, per share


158,209


154,307


151,561


146,058


137,688

    Funds from operations, diluted, as adjusted, per share


158,209


154,307


151,561


146,058


137,688

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-at-the-vanguard-of-the-life-science-industry-reports-1q22-net-loss-per-share--diluted-of-0-96-1q22-ffo-per-share--diluted-as-adjusted-of-2-05--301532273.html

SOURCE Alexandria Real Estate Equities, Inc.

Copyright 2022 PR Newswire

Alexandria Real Estate E... (NYSE:ARE)
Historical Stock Chart
Von Jun 2022 bis Jul 2022 Click Here for more Alexandria Real Estate E... Charts.
Alexandria Real Estate E... (NYSE:ARE)
Historical Stock Chart
Von Jul 2021 bis Jul 2022 Click Here for more Alexandria Real Estate E... Charts.